Cellvizio I.V.E. with Confocal Miniprobes— 510(k) K193416
Substantially EquivalentMauna Kea Technologies
FDA 510(k) clearance K193416 for Cellvizio I.V.E. with Confocal Miniprobes, Substantially Equivalent on 2020-02-28. Applicant: Mauna Kea Technologies.
Clearance details
- Applicant
- Mauna Kea Technologies
- Product code
- Code OWN
- Advisory panel
- Gastroenterology, Urology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Paris, FR
Adverse events under product code OWN
product code OWN- Malfunction
- 1,286
- Total
- 1,286
Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →
Data sourced from openFDA. This site is unofficial and independent of the FDA.